Press Releases

February 07, 2006

Gilead Sciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Wednesday, February 8th; Webcast Available Through Gilead Corporate Website

FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 7, 2006--Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its corporate presentation will be webcast from the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference, in New York, NY. This webcast may be accessed via the company's corporate website at www.gilead.com.

John F. Milligan, PhD, Gilead's Executive Vice President and Chief Financial Officer, will provide an overview of the company including an update on Gilead's integrase inhibitor clinical programs on Wednesday, February 8th at 2:20 p.m. Eastern Time.

To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

CONTACT: Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715
SOURCE: Gilead Sciences, Inc.